Trial Profile

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 07 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nivolumab (Primary) ; Nivolumab (Primary)
Indications Basal cell cancer
Focus Therapeutic Use

Most Recent Events

18 Dec 2021 Status changed from recruiting to completed.
11 Sep 2020 Planned End Date changed from 5 Nov 2020 to 5 Dec 2021.
11 Sep 2020 Planned number of patients changed from 24 to 20.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com